comparemela.com
Latest Breaking News On - Charlene liao phd - Page 1 : comparemela.com
IO-202 Receives FDA Orphan Drug Designation for CMML
The FDA has granted IO-202 an orphan drug designation for patients with chronic myelomonocytic leukemia.
Germany
Onc-therapeutics-inc
European-hematology-association-congress
Liao-phd
Onc-therapeutics
Hematology-association-congress
Io-202
Patients-with-chronic-myelomonocytic-leukemia
Charlene-liao-phd
Nct04372433
vimarsana © 2020. All Rights Reserved.